You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Dec 27, 2022

Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

Not yet recruiting
  • Acute Myeloid Leukemia
  • bone marrow aspirate and biopsy
  • (no location specified)
Aug 20, 2022

Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    Jun 10, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti-siglec-6 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Aug 2, 2022

    Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CIML-NK Cells
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jan 4, 2023

    Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • B7-H3 target, CAR gene modified gdT cell injection
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital， Zhejiang University School of Med
    Feb 15, 2023

    Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Miami, Florida
      University of Miami
    Dec 22, 2022

    Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 13, 2022

    Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

    Not yet recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • LILRB4 STAR-T cells
    • (no location specified)
    Sep 16, 2022

    AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

    Not yet recruiting
    • AML
    • Acute Myeloid Leukemia
    • DREAMLAND
    • CERENA
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 12, 2022

    Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Poznań, Poland
      Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
    Jun 30, 2022

    Analyze Occurrence of Transformation From Myelodysplastic

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
      • Kobe, Hyogo, Japan
        Shinko Hospital
      Jun 13, 2022

      Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

      Terminated
      Has Results
      • Acute Myeloid Leukemia (AML)
      • Allogeneic HCT
      • Consolidation chemotherapy
      • Charlotte, North Carolina
        Levine Cancer Institute
      Apr 19, 2022

      Mold Infections in Children During Leukemia Treatment

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Acute Lymphoblastic Leukemia
        • Odense, Denmark
          Rasmus Møller Duus
        Mar 7, 2023

        Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)

        Not yet recruiting
        • Relapsed or Refractory Acute Myeloid Leukemia (AML)
        • Mitoxantrone Hydrochloride Liposome
        • (no location specified)
        Apr 19, 2022

        Healthcare Resource Utilization in Adults Diagnosed With Acute

        Completed
        • Acute Myeloid Leukemia (AML)
        • Helsinki, Finland
          Novartis Investigative Site
        Aug 3, 2022

        Acute Myeloid Leukemia Trial (Sulfasalazine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Oct 11, 2022

        Acute Myeloid Leukemia Trial (with or without venetoclax)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • with or without venetoclax
        • (no location specified)
        Apr 29, 2022

        Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

        Recruiting
        • Relapsed or Refractory Acute Myeloid Leukemia
        • Taiyuan, Shanxi, China
          Tao Wang
        Feb 9, 2023

        Acute Myeloid Leukemia Trial in Xi'an (infusion of natural killer cells)

        Recruiting
        • Acute Myeloid Leukemia
        • infusion of natural killer cells
        • Xi'an, Shaanxi, China
          First Affiliated Hospital of Xian Jiaotong University
        Apr 17, 2022

        Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Acute Myeloid Leukemia Recurrent
        • CD123-CAR-NK cells
        • Beijing, Beijing, China
          The Fifth Medical Center of Chinese People's Liberation Army (PL
        Oct 24, 2022

        Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

        Recruiting
        • Relapsed/Refractory Acute Myeloid Leukemia
        • gdT cell injection targeting B7-H3 chimeric antigen receptor
        • Hefei, Anhui, China
          PersonGen Anke Cellular Therapeutice Co., Ltd.
        Jan 31, 2023